Author: Nicholas Caito

Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators.

Hart K.M., Moeder K.E., Ho C.M.W., Zimmerman M.I., Frederick T.E., & Bowman G.R. (2017). “Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators.” PLoS One. 2017 Jun 1;12(6):e0178678. doi: 10.1371/journal.pone.0178678. eCollection 2017. (Abstract)

A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.

Frieden C., Wang H., & Ho C.M.W. (2017). “A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.” Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6292-6297. doi: 10.1073/pnas.1705080114. Epub 2017 May 30. (Abstract)

Whitney Grither awarded 2017 DeGutis Prize in Chemical Biology/Medicinal Chemistry

On May 5th, 2017, Whitney Grither was awarded the 2017 Ceil M. DeGutis Prize in Chemical Biology/Medicinal Chemistry. Whitney presented her research entitled: Selective Small Molecule Inhibition of Discoidin Domain Receptor 2. Whitney graduated this Spring from the Biochemistry graduate program. She finished her PhD work in the laboratory of Dr. Greg Longmore with the express purpose of identifying novel modes of inhibiting an underappreciated collagen receptor, DDR2, which they had just shown was critical for breast cancer metastasis in experimental mouse models and humans (Nature Cell Biology, 2013). (more…)

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease.

Mydock-McGrane L.K., Hannan T.J., & Janetka J.W. (2017). “Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease.” Expert Opin Drug Discov. 2017 Jul;12(7):711-731. doi: 10.1080/17460441.2017.1331216. Epub 2017 Jun 2. (Abstract)